A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.
Clinical trial NCT04194645 · COMPLETED
Trial details
- NCT number
- NCT04194645
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2021-03-25
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.